Chandler Chicco Named "Healthcare Agency of the Decade" by The Holmes Report


NEW YORK, Jan. 19, 2010 (GLOBE NEWSWIRE) -- Chandler Chicco, part of inVentiv Health (Nasdaq:VTIV), was named 'Healthcare Agency of the Decade' in the January 9 issue of The Holmes Report, an online publication which reports public relations industry news, trends and analysis. The report lauded Chandler Chicco’s growth and prosperity as a specialist agency, stating the agency is “perhaps the fastest-growing midsized firm of the past 10 years.”

Chandler Chicco was one of five specialist agencies recognized by the report as continuing to flourish throughout the past decade, outperforming many large global agencies. The report notes that over the past decade, the agency "became a benchmark for quality in healthcare communications, built a roster that includes almost every major pharmaceutical company in the world, grew its European operations until it was the largest healthcare specialist in the region, remained a fixture on our ‘Best Agency to Work For’ list, and won awards in the U.S. and Europe for its creative and strategic programming.”

“We are extremely honored by the award and the accompanying article from The Holmes Report,” said Chandler Chicco co-founder Bob Chandler. “We are particularly grateful to our clients and employees for helping us to achieve such success over the past decade.”

Since 2000, Chandler Chicco has quadrupled in size, expanded into European markets, developed design, research and advertising capabilities, and became part of healthcare services holding company inVentiv Health in 2007. The agency currently offers public relations and communications counsel to a list of over 40 clients, including hospitals, NGOs, healthcare associations, coalitions, and many of the world’s largest pharmaceutical companies.

About Chandler Chicco Companies

Chandler Chicco Companies (CCC) is a network of global companies representing best-in-class capabilities in healthcare communications across public relations, marketing and branding, digital and social media, graphic design, media and production, and research and measurement. Current CCC companies include: Chandler Chicco Agency, Biosector 2, Litmus, Determinus, ‘nition, Allidura Consumer, Brandtectonics, VerStone Digital and Chandler Chicco Productions.

CCC has wholly-owned offices in London, Los Angeles, Paris, New York and Washington, DC and also has a global affiliate healthcare network of 22 national companies operating across 37 markets. For more information, visit www.chandlerchiccocompanies.com

About inVentiv Health

inVentiv Health, Inc. (Nasdaq:VTIV) is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 350 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit http://www.inventivhealth.com/">www.inventivhealth.com.

The inVentiv Health, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4942

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors.

 



            

Coordonnées